Global Immunohistochemistry (IHC) Market is Expected to be Worth US$ 2,020.2 Million in 2021 and US$ 3,348.7 Million by 2028, Growing at a CAGR of 7.5% During The Forecast Period (2021-2028)

Immunohistochemistry (IHC)
Immunohistochemistry (IHC)

IHC is a technique that combines anatomical, immunological, and biochemical methods to visualize discrete components in tissues using appropriately labeled antibodies that bind to their target antigens in situ. IHC enables scientists to see and describe the high-resolution distribution and localization of specific cellular components within cells and their histological context. While there are many different approaches and permutations to IHC methodology, all of the processes fall into two categories: sample preparation and sample staining. IHC is used to diagnose diseases, conduct biological research, and test drugs.

The global Immunohistochemistry (IHC) Market will be boosted by the growing elderly population in both developed (such as the United Kingdom, Canada, and others) and developing countries (such as India, Brazil, China, and others). As the global geriatric population grows, the prevalence of age-related disorders is expected to rise significantly. According to the Organisation for Economic Co-operation and Development (OECD), the United States had 54 million elderly people in 2019. 

In other developed economies around the world, geriatric populations are also significant and growing. A person's risk of contracting diseases rises in direct proportion to his or her age. As a result, as the world's elderly population grows, the global prevalence of diseases like cancer, cardiovascular disease, and others is expected to rise. Because of its well-developed healthcare infrastructure, North America is expected to dominate the Global Immunohistochemistry (IHC) Market during the forecast period. In addition, IHC instruments are becoming more widely used in laboratories and diagnostic centers. 

The favorable reimbursement structure in this region is helping automated Immunohistochemistry (IHC) Market share. Cancer rates are also rising in this region, driving up demand for IHC procedures and resulting in profitable market expansion. According to the National Institutes of Health (NIH), approximately 1,806,590 new cases of cancer will be diagnosed in the United States in 2020, with 606,520 people dying from the disease.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030